Search results
Results from the WOW.Com Content Network
At the time, ZymoGenetics did not plan on closing its Bothell manufacturing site; [14] however, it was sold to Seattle Genetics in August 2017. [16] ZymoGenetics closed completely in 2019. [ 3 ] [ 4 ]
Edward John Rebar is an American biologist, and is senior vice president and chief technology officer of Sana Biotechnology. [1] Education
Seattle Genetics was founded in 1997, by Henry Perry Fell, Jr. [10] and Clay Siegall, [11] and is headquartered in Bothell, Washington, a suburb of Seattle. The company completed an initial public offering in March 2001, and prior to its acquisition by Pfizer, it was traded on the Nasdaq Stock Market under the symbol SGEN, and was a component ...
For premium support please call: 800-290-4726 more ways to reach us
[4] [64] Icos was the largest biotechnology company in the state of Washington at the time of the acquisition, and employed around 700 people. [4] [65] In December 2007, CMC Biopharmaceuticals A/S, a Copenhagen-based provider of contract biomanufacturing services, bought the Bothell biologics facility and retained the existing 127 employees. [4]
Richard C. Mulligan (born 1954) is an American scientist who is the Mallinckrodt Professor of Genetics at Harvard Medical School, [1] [2] [3] the Director of the Harvard Gene Therapy Initiative and a visiting scientist at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. [4]
San Francisco, CA: No. 49, down 19 points from 2024. Contributing: Gabe Hauari, Andrea Riquier, USA TODAY. This article originally appeared on USA TODAY: Zillow's hottest housing markets of 2025 ...
Juno Therapeutics Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.